Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.98
Bid: 15.90
Ask: 16.00
Change: -0.24 (-1.48%)
Spread: 0.10 (0.629%)
Open: 16.30
High: 16.46
Low: 15.86
Prev. Close: 16.22
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EnQuest signs sale and purchase agreement

31 Jul 2020 07:00

RNS Number : 6827U
EnQuest PLC
31 July 2020
 

 

EnQuest PLC, 31 July 2020

EnQuest signs sale and purchase agreement for equity interest in the Bressay Oil Field

EnQuest PLC (together with its subsidiaries, 'EnQuest'), an independent oil and gas production and development company listed on the London and Stockholm stock exchanges (ENQ.L and ENQ.ST), is pleased to announce it has signed a sale and purchase agreement ('SPA') with Equinor to purchase a 40.81% equity interest in the Bressay oil field. Completion of the transaction is subject to the satisfaction of a number of conditions precedent. Under the terms of the SPA and subject to all partner approvals, EnQuest will also assume operatorship of the licences following the plugging and abandonment of the 3/28-1 well by Equinor. The initial consideration is £2.2 million payable as a carry against 50% of Equinor's net share of costs from the point EnQuest assumes operatorship. EnQuest will also make a contingent payment of $15 million following OGA approval of a Bressay field development plan. There are no gross assets or profit before tax associated with the assets.

Highlights

§ 40.81% equity and operatorship for an initial consideration of £2.2 million

§ Payable as a carry against 50% of Equinor's net share of costs from completion

§ A contingent payment of $15 million to Equinor on regulatory approval of a Bressay field development plan*

§ Low-cost addition of up to 115 MMbbls (net) 2C resources, depending on development concept

§ ~65% increase in EnQuest's 2C resources from 173 MMbbls to 288 MMbbls

§ A number of development scenarios are under consideration, including a potential tie back to Kraken, reducing emissions, costs and extending its field life

§ No material near-term capital commitments

§ If developed via Kraken, Bressay produced gas may be used for fuel for the FPSO, reducing carbon emissions over the longer term

§ Aligned with EnQuest's proven capabilities in heavy oil, drilling and low risk subsea tie backs

§ Establishes a strategic partnership with Equinor, jointly leveraging UKCS development capabilities

§ Appropriate extensions to licence expiry dates and commitments are condition precedents to completion

 

EnQuest Chief Executive, Amjad Bseisu, said:

"We are delighted we have agreed the acquisition of a material operating interest in the Bressay field and to partner with Equinor. With the addition of up to 115 MMbbls of net 2C resources, Bressay provides EnQuest an opportunity to demonstrate its proven capabilities in low-cost drilling, near-field and heavy oil development. The heavy oil skills and knowledge the Group has acquired from Kraken will help us unlock the potential of this large 1 billion bbl oil in place field. We would like to thank Equinor for their confidence in our capabilities and we look forward to a productive partnership with Equinor and Chrysaor."

 

Ends

Notes to editors

Bressay is a heavy oil field in the Northern North Sea located in 110 metres water depth and 12 kilometres Northeast of the EnQuest operated Kraken heavy oil field. Bressay is one of the largest undeveloped oil fields in the UKCS with an estimated stock-tank oil initially in place ('STOIIP') of 600 to 1,050 MMbbls. The field was discovered in 1976 and has been appraised through the drilling and testing of four further wells, with flow rates of up to 2,900 bopd achieved.

The Bressay field is located across four UK licence blocks: P234, P493, P920 and P977. Each of these licence blocks has the same equity partnership. Current partners in the Bressay field are Equinor (81.62%) and Chrysaor (18.38%).

\* The contingent payment increases to $30 million in the event that EnQuest sole risks Equinor in the submission of the field development plan.

For further information please contact:

 

EnQuest PLC Tel: +44 (0)20 7925 4900

Amjad Bseisu (Chief Executive)

Jonathan Swinney (Chief Financial Officer)

Ian Wood (Head of Communications and Investor Relations)

Jonathan Edwards (Senior Investor Relations and Communications Manager) 

Tulchan Communications Tel: +44 (0)20 7353 4200

Martin Robinson

Martin Pengelley

 

Notes to editors

 

ENQUEST

EnQuest is an independent production and development company with operations in the UK North Sea and Malaysia. The Group's strategic vision is to be the operator of choice for maturing and underdeveloped hydrocarbon assets by focusing on operational excellence, differential capability, value enhancement and financial discipline.

EnQuest PLC trades on both the London Stock Exchange and the NASDAQ OMX Stockholm. Its UK operated assets include Thistle/Deveron, Heather/Broom, the Dons area, Magnus, the Greater Kittiwake Area, Scolty/Crathes and Kraken; EnQuest also has an interest in the non-operated Alba producing oil field. At the end of June 2020, EnQuest had interests in 17 UK production licences and was the operator of 15 of these licences. EnQuest's interests in Malaysia include the PM8/Seligi and PM409 Production Sharing Contracts, both of which the Group operates.

Forward-looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectations and plans, strategy, management's objectives, future performance, production, reserves, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this announcement should be construed as a profit forecast. Past share performance cannot be relied upon as a guide to future performance.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRKKKBKFBKDNON
Date   Source Headline
9th Sep 201911:44 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSChairman Succession
5th Sep 20197:00 amRNSResults for the six months ended 30 June 2019
2nd Sep 201912:04 pmRNSHolding(s) in Company
28th Aug 20193:22 pmRNSTotal Voting Rights
29th Jul 20199:27 amRNSTotal Voting Rights
17th Jul 201911:30 amRNSDirector/PDMR Shareholding
12th Jul 20193:00 pmRNSDirector/PDMR Shareholding
9th Jul 20199:15 amRNSDirector/PDMR Shareholding
1st Jul 20192:48 pmRNSDirector/PDMR Shareholding
27th Jun 20192:24 pmRNSReport on Payments to Govts
26th Jun 201911:54 amRNSTotal Voting Rights
25th Jun 20193:46 pmRNSDirector/PDMR Shareholding
18th Jun 201911:30 amRNSDirector/PDMR Shareholding
10th Jun 20192:33 pmRNSDirector/PDMR Shareholding
5th Jun 20194:12 pmRNSDirector/PDMR Shareholding
3rd Jun 201912:08 pmRNSDirector/PDMR Shareholding
30th May 20198:30 amRNSBlock Listing Application
28th May 20194:28 pmRNSDirector/PDMR Shareholding
23rd May 20194:54 pmRNSAGM Statement
23rd May 20197:00 amRNSOperations Update
20th May 20193:10 pmRNSDirector/PDMR Shareholding
13th May 20194:15 pmRNSDirector/PDMR Shareholding
8th May 201912:50 pmRNSDirector/PDMR Shareholding
26th Apr 20194:34 pmRNSDirector/PDMR Shareholding
17th Apr 20194:00 pmRNSNotice of AGM and Report & Accounts
8th Apr 201910:20 amRNSDirector/PDMR Shareholding
1st Apr 201911:36 amRNSDirector/PDMR Shareholding
27th Mar 20192:35 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSBoard Appointment
12th Mar 20197:11 amRNSKraken 2P Reserves
5th Feb 20197:00 amRNSOperations update
30th Jan 20193:22 pmRNSBoard Committee Membership
28th Jan 201911:31 amRNSChange of Directors' Details
23rd Jan 201910:08 amRNSHolding(s) in Company
18th Jan 20194:09 pmRNSDirector/PDMR Shareholding
17th Dec 201812:22 pmRNSChange of Director's Details
5th Dec 20187:00 amRNSOperations update
3rd Dec 20187:00 amRNSCompletion of Magnus Transaction
26th Nov 201811:56 amRNSDirector/PDMR Shareholding
16th Nov 201812:10 pmRNSHolding(s) in Company
1st Nov 20182:29 pmRNSDirector/PDMR Shareholding
31st Oct 20189:38 amRNSTotal Voting Rights
24th Oct 201812:11 pmRNSDirector/PDMR Shareholding
23rd Oct 20184:47 pmRNSDirector/PDMR Shareholding
22nd Oct 20186:14 pmRNSResults of Rump Placing
22nd Oct 20187:00 amRNSResult of Rights Issue
4th Oct 20187:00 amRNSMagnus and Thistle Options exercised
2nd Oct 20183:12 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.